Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., will be featuring LACRIFILL Canalicular Gel, a novel therapy for dry eye symptoms, at the American Academy of Ophthalmology Annual Meeting in ...

US FDA approves Celltrion’s Eydenzelt biosimilar referencing Eylea to treat wAMD, macular edema following RVO, DME and diabetic retinopathy: Incheon, South Korea Monday, October ...

Visara is launching with $37 million from I-Mab and will be led by Emmett Cunningham Jr., M.D., Ph.D., an ophthalmologist and ...

Blurred vision can be a sign of a brain stroke. A 34-year-old man's persistent visual blurring was initially missed by eye ...

Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving UME and may offer a potential new treatment option for patientsVision improvements were seen in both ...

Biopharmaceutical company Celltrion on Friday said its biosimilar for eye diseases has received approval for sale in the US ...

It appears problems at Novo Nordisk’s recently acquired manufacturing facility in Indiana aren’t going to be solved any time ...

The FDA has approved Celltrion's Eydenzelt, a new aflibercept biosimilar, enhancing treatment options for retinal diseases in the US.

Zoller + Fröhlich, more familiarly known as Z+F, is not new to the spotlight. For years, its laser scanners have been the silent workhorses behind some of the most demanding tasks ...

Older players of pickleball, the fastest-growing sport in the United States, are more vulnerable to eye injuries, some of ...

Safety precautions haven't caught up with enthusiasm for the sport. Researchers call for a new push for eye-ware.

Professional dry eye treatment services offer essential relief for individuals suffering from this prevalent ocular condition ...